Výsledky vyhledávání - "Fita, M. J. Juan"

Akademický článek

860TiPPhase II trial evaluating olaparib maintenance in patients with MCRPC after docetaxel treatment reaching partial or stable response.

Autor: Fita, M J Juan¹ (AUTHOR), Lopez, L Heras² (AUTHOR), Mellado, B³ (AUTHOR), Vidal, M J Mendez⁴ (AUTHOR), Anido, U⁵ (AUTHOR), Lorente, D⁶ (AUTHOR), Sepulveda, J M⁷ (AUTHOR), Alvarez, C⁸ (AUTHOR)

Publikováno v: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Zobrazit plný text záznamu

Akademický článek

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.

Autor: Pérez-Valderrama, B.¹ bperezv@gmail.com, Arija, J. A. Arranz², Sánchez, A. Rodríguez³, Marín, A. Pinto⁴, García, P. Borrega⁵, Gaunas, D. E. Castellano⁶, Romero, G. Rubio⁷, Alonso, C. Maximiano⁸, Guzmán, J. C. Villa⁹, Álvarez, J. L. Puertas¹⁰, González, I. Chirivella¹¹, Vidal, M. J. Méndez¹², Fita, M. J. Juan¹³, León-Mateos, L.¹⁴, Quintela, M. Lázaro¹⁵, Domínguez, R. García¹⁶, García, J. M. Jurado¹⁷, de Mendizábal, E. Vélez¹⁸, Sorrosal, J. J. Lambea¹⁹, Carbonero, I. García²⁰

Publikováno v: Annals of Oncology. Apr2016, Vol. 27 Issue 4, p706-711. 6p. 2 Charts, 1 Graph.

Zobrazit plný text záznamu

Akademický článek

822PPreliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel.

Autor: Puente, J¹ (AUTHOR), Vidal, M J Mendez² (AUTHOR), Saez, M I³ (AUTHOR), Pous, A Font⁴ (AUTHOR), Duran, I⁵ (AUTHOR), Castellano, D⁶ (AUTHOR), Fita, M J Juan⁷ (AUTHOR), Santander, C⁸ (AUTHOR), Arija, J A Arranz⁹ (AUTHOR), Sanchez-Hernandez, A¹⁰ (AUTHOR)

Publikováno v: Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.

Zobrazit plný text záznamu